Filing Details
- Accession Number:
- 0001209191-18-054429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-05 17:28:44
- Reporting Period:
- 2018-10-03
- Accepted Time:
- 2018-10-05 17:28:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-03 | 2,118 | $125.71 | 6,997 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-03 | 2,118 | $192.13 | 4,879 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-10-03 | 4,700 | $126.68 | 9,579 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-03 | 4,700 | $192.13 | 4,879 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-10-03 | 2,118 | $0.00 | 2,118 | $125.71 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-10-03 | 4,700 | $0.00 | 4,700 | $126.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,177 | 2027-05-31 | No | 4 | M | Direct | |
| 14,547 | 2025-06-03 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Bhatia's company-approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 6/1/2017.
- The option vests in 16 quarterly installments from 6/4/2015.
Billionaire Hedge Funds
